Stay updated with breaking news from Gene Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Food Standards Australia New Zealand (FSANZ) is seeking public comment on its proposed approach to changing the definitions for ‘food produced using
Rise and Shine: What you need to know before the ASX opens News share clipboard But first … the day ahead. Scheduled to list at 11am AEST is NobleOak Life (ASX:NOL), a 144-year-old life insurance firm that has its roots in the ancient Celtic tradition of the druids. A first time for everything when you invest on the ASX. Also this morning a new copper-gold miner in Queensland will emerge through the shell of former marketing and IR firm R3D Global when R3D Resources (ASX:R3D) relists after a $4.25 million recapitalisation. TRADING HALTS The following companies are in trading halts and ...
Date Time Ban on GM crops no more Today marks an historic new opportunity for the state’s farmers to increase their competitiveness and productivity, as the NSW Government lifts its ban on the use of Genetically Modified (GM) crops. Minister for Agriculture Adam Marshall announced the lapse of the 18-year moratorium today and said it would not be renewed, opening the door for the state’s primary industries sector to embrace new GM technologies. “By lifting the ban we hope to unlock the potential of GM crops for our state’s growers, delivering better yields with less inputs such as pes...
International Trade in Crops with New Breeding Technologies: The Australian Perspective June 9, 2021 ISAAA and partners present the webinar International Trade in Crops with New Breeding Technologies: The Australian Perspective to provide an insight into the future landscape of trade involving gene-edited crops, particularly in relation to countries involved in the international trade of agricultural products. It will be held on June 11, 2021, at 2 PM Manila / 4 PM Sydney via Zoom. Developments in regulations of gene-edited plants are changing rapidly. Increasingly more countries, i...
Data suggest that autologous administration of BM-MSCs in the treatment of T2DM should be performed in patients with T2DM duration <10 years and no obesity.